Social Media Ideas for Pharmaceuticals Industry

<![CDATA[What FDA's Peptide Decision Means for the Industry]]>

Quality Reforms, Biopharma Ecosystem Top Priority to Keep India as ‘Pharmacy of World’: Pharma Secy Manoj Joshi

Joshi highlighted the industry’s long-term challenges, including building a robust biopharma ecosystem and reducing dependence on imported APIs

Mid-Year Updates in the Pharmaceutical and Healthcare Industry

<![CDATA[Pharmaceutical Executive Daily: Pharm Exec Ranks Top 50 Companies of 2026]]>

<![CDATA[The Industry’s Shift on RWD]]>

<![CDATA[2026 Pharm Exec Top 50 Companies]]>

<![CDATA[How Pharmaceutical Executives Can Navigate the Changing Pharmaceutical Landscape]]>

SA Asks: What's the outlook for Big Pharma M&A?

<![CDATA[What Executives and Investors Are Looking for in Pharma Companies]]>

How the machine runs

Learn how pharma companies build durable businesses through doctors, sales networks and chronic therapies, and why regulatory risks can change fortunes overnight.

India tightens drug quality norms, eyes biopharma push: Pharma Secretary

Manoj Joshi said restoring confidence in India's pharmaceutical manufacturing through stricter regulation is the government's immediate priority

<![CDATA[Your Questions Answered: The Biggest Pharma and Biotech Stories This Week]]>

<![CDATA[Pharma M&A Roundup: Oak Hill Bio Combines with RACC, Apnimed Plans $150 Million IPO, CORE Biomedicine Se...

<![CDATA[CSPC Pharmaceutical & AstraZeneca Form Joint Venture for Biologics Manufacturing in China]]>

<![CDATA[Taking a Hard Look at Pharma's Traditional Margin Model]]>

<![CDATA[How Regulators and the Industry Can Work Together to Improve the US Pharma Ecosystem ]]>

<![CDATA[Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals ]]>

<![CDATA[The Structural Problems Causing the Pharma and Biotech Industries’ Compliance Failures]]>

<![CDATA[Implementing a scalable pharmaceutical serialization system]]>

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Enters $2.8 Billion Agreement to Acquire Merida Biosciences]]>

Regulatory Affairs and Pharmacovigilance in India

Regulatory Affairs and Pharmacovigilance in India: A Lifecycle Approach for Pharma & Medical Device CompaniesIndia is a major pharmaceutical and medical device market, but succ...

<![CDATA[The New Pharma Visibility Journey]]>

<![CDATA[The Operational Reality of Reshoring Pharma Manufacturing: Q&A with Rohit Tripathi]]>

<![CDATA[Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs]]>